Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Updates & Corrections
Clarification 09 October 2021: This story was updated to clarify that the two Indian drugmakers testing a generic version of molnupiravir did so independently of Merck, and to add comments from Merck indicating that moderate cases of COVID-19 in India are defined as being more severe than those in the United States.
Beigel, J. H. et al. N. Engl. J. Med. 383, 1813-1826 (2020).
Sheahan, T. P. et al. Sci. Transl. Med. 12, eabb5883 (2020).
Cox, R. M. et al. Nature Microbiol. 6, 11-18 (2021).